CN113413431A - 一种用于预防和治疗高血压的中药组方 - Google Patents
一种用于预防和治疗高血压的中药组方 Download PDFInfo
- Publication number
- CN113413431A CN113413431A CN202110845957.6A CN202110845957A CN113413431A CN 113413431 A CN113413431 A CN 113413431A CN 202110845957 A CN202110845957 A CN 202110845957A CN 113413431 A CN113413431 A CN 113413431A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- traditional chinese
- chinese medicine
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 36
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 241000545744 Hirudinea Species 0.000 claims abstract description 12
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 12
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 12
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 12
- 235000016811 Biondella Nutrition 0.000 claims abstract description 11
- 241000522190 Desmodium Species 0.000 claims abstract description 11
- 241001530209 Swertia Species 0.000 claims abstract description 11
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 11
- 235000011477 liquorice Nutrition 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 241001522129 Pinellia Species 0.000 claims abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 8
- 235000008397 ginger Nutrition 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 235000002710 Ilex cornuta Nutrition 0.000 claims description 6
- 241001310146 Ilex cornuta Species 0.000 claims description 6
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims description 6
- 241001483116 Neopicrorhiza scrophulariiflora Species 0.000 claims description 2
- 241000234314 Zingiber Species 0.000 claims 3
- 230000036772 blood pressure Effects 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004185 liver Anatomy 0.000 abstract description 19
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 7
- 208000026435 phlegm Diseases 0.000 abstract description 7
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 6
- 210000000056 organ Anatomy 0.000 abstract description 6
- 244000273928 Zingiber officinale Species 0.000 abstract description 5
- 210000004204 blood vessel Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 4
- 241000202726 Bupleurum Species 0.000 abstract description 3
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 230000002503 metabolic effect Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 3
- 230000004087 circulation Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000007102 metabolic function Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 description 14
- 208000002173 dizziness Diseases 0.000 description 12
- 206010019233 Headaches Diseases 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000007530 Essential hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 201000004239 Secondary hypertension Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000006694 eating habits Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000020 effect on hyperlipemia Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000005747 tumor angiogenesis Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种用于预防和治疗高血压的中药组方,其由水蛭、地龙、胡黄连、地骨皮、姜半夏、鱼腥草、甘草、柴胡、元胡、大青叶、青黛、四季青、青箱子、龙胆草、金钱草组成。本发明结合高血压的致病原因,主要以对肝、胃、脾等脏器同调为原则,各原料药协同作用,具有祛痰、化湿、活血,利气、清热解毒、行滞化瘀等功效,不仅可化栓疏通血管,并且通过增强中焦脾胃代谢机能,加速排除血管中毒素等代谢垃圾,达到稳定降压的效果;并且通过柴胡等增强气血运行,使得人体维持阴阳平衡,调理和保护全身脏腑,维持血压正常。
Description
技术领域
本发明涉及中药技术领域,尤其涉及一种用于预防和治疗高血压的中药组方。
背景技术
高血压,也称血压升高,是一种以循环动脉血压持续升高为主的全身性慢性疾病。心脏每一次收缩,会将血液压送进血管,并通过血管将血液输送至全身,心脏压送血液推挤血管壁(动脉)所产生的压力即为血压。血压越高,心脏压送血液所用的力就越大。正常成年人的心脏收缩时,血压值(收缩压)约为120毫米汞柱,心脏舒张时,血压值(舒张压)约为80毫米汞柱。当收缩压持续大于或等于140毫米汞柱、舒张压持续大于或等于90毫米汞柱时,就视为血压升高,即高血压。高血压患者常常会出现头晕、头痛等症状,有些人还会伴随眼花、耳鸣、失眠、乏力等一系列症状,严重时还可导致恶心、呕吐、腿脚抽搐、神志不清等症状,以往多发病于中老年人,近年来高血压的发病人群逐渐趋于年轻化。很多40岁左右甚至35岁左右的年轻人就已经开始出现血压波动升高的现象,但大部分人都认为出现后脑紧绷或头晕头痛症状是由于颈椎的不适所导致,并没有充分的重视,逐渐的就发展成为高血压。引起该疾病的诱发因素有很多,例如年龄因素、遗传因素、生活习惯、饮食习惯、缺乏锻炼、药物影响以及甲状腺、糖尿病等疾病因素都可导致高血压的发生。
高血压有原发性高血压和继发性高血压之分,继发性高血压约占5%,原发性高血压病是以血压升高为主要临床表现的综合征,简称高血压。高血压是多种心、脑血管疾病的重要病因和危险因素,影响重要脏器如心、脑、肾的结构和功能,最终导致这些器官的功能衰竭,迄今为止是心脑血管疾病死亡的主要原因之一。
在高血压病的治疗过程中,化学药虽然作用迅速,但降压过程中血压波动大,副作用也大,可明显影响水,电解质,血脂,血糖等的代谢;直接损伤心、脑、肾等器官,同时这些药物对高血脂,高血粘、血管硬化,靶器官的损伤等无改善作用。
发明内容
因此,基于以上背景,本发明提供一种可以稳降压,疗效显著,无副作用,且可有效缓解头痛、头晕、心悸、胸闷、乏力等高血压临床症状的用于预防和治疗高血压的中药组方。
本发明的通过以下技术方案实现:
一种用于预防和治疗高血压的中药组方,其由以下原料药组成:
水蛭、地龙、胡黄连、地骨皮、姜半夏、鱼腥草、甘草、柴胡、元胡、大青叶、青黛、四季青、青箱子、龙胆草、金钱草。
进一步地,按重量计,所述原料药用量为:
水蛭5-50份、地龙3-30份、胡黄连5-30份、地骨皮10-60份、姜半夏3-30份、鱼腥草10-60份、甘草10-200份、柴胡10-100份、元胡5-50份、大青叶5-50份、青黛3-15份、四季青5-50份、青箱子5-50份、龙胆草5-50份、金钱草10-50份。
进一步地,按重量计,所述原料药用量为:
水蛭30份、地龙25份、胡黄连20份、地骨皮40份、姜半夏25份、鱼腥草40份、甘草60份、柴胡50份、元胡35份、大青叶30份、青黛12份、四季青35份、青箱子40份、龙胆草30份、金钱草35份。
进一步地,本发明可以加入制备不同剂型时所需的各种常规辅料以制备成任何一种常用口服剂型,如:丸剂、散剂、片剂、胶囊剂、口服剂等。
本发明中:水蛭:性平,味苦、咸,归肝经,破血,逐瘀,通经等,具有凝血、抗血栓、保护脑神经、降低血黏度、促进血液循环、抑制肿瘤血管生成等作用。地龙:性寒,味咸,归肝、脾、膀胱经,清热定惊,通络活络、清肺平喘、清热利尿等,具有溶栓和抗凝、降血压等作用;胡黄连:性寒,味苦,归肝、胃、大肠经,清湿热,凉血等,具有保肝、利胆、抗真菌等作用;地骨皮:性寒,味甘,归肺、肝、肾经,凉血除蒸,清肺降火等,具有清泄肺热、降血糖、解热等作用;姜半夏:性温,味辛,归脾、胃、肺经,燥湿化痰,降逆止呕,消痞散结等,具有镇咳、抑制腺体分泌、镇吐和催吐、抗发育、对胰蛋白酶的抑制、降压、凝血等作用;鱼腥草:性微寒,味辛,归肺经,清热解毒,消痈排脓,利尿通淋,具有抗菌、抗病毒、利尿、镇痛、止血、抑制浆液分泌、促进组织再生等作用;甘草:性平,味甘,归心、肺、脾、胃经,补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药等,具有解毒、抗炎及抗变态反应、祛痰、镇咳、解痉、抗肝损伤等作用;柴胡:性微寒,味苦,归肝、胆经,和解表里,疏肝,升阳,具有解热、镇静、镇痛、抗炎、抗病原体、降压、利胆等作用;元胡:性温,味辛、苦,归肝、脾经,活血,利气,止痛,具有止痛、镇痛等作用;大青叶:性寒,味苦,归心、胃经,清热解毒,凉血消斑,具有抗菌、抗癌、解热、利胆、对血小板聚集等作用;青黛:性寒,味咸,归肝经,清热解毒,凉血,具有抗肿瘤、提高机体免疫能力、抑菌等作用;四季青:性温,味辛,清热解毒,排脓生肌,活血,具有抗菌、收敛等作用;青箱子:性寒,味苦,归肝、膀胱经,燥湿清热,凉血止血,具有抗菌杀虫、解热、降压等作用;龙胆草:性寒,味苦,归肝、胆经,清热燥湿,泻肝胆火,具有促进胃液分泌和使游离酸增加、利胆、保肝、利尿、抗菌等租用;金钱草:性凉,味苦、辛,归肺、肝经,清热、利湿、解毒,具有排石、抗炎等作用。
中医认为高血压是由于肝肾阴虚导致的肝阳上亢或肝风内动所致,但是经研究高血压的形成与饮食习惯、生活方式密不可分,而传统中医认为“脾胃为后天之本,气血生化之源,气为血之帅,血为气之母,气血运行需要气的推动和血的滋养”,脾胃功能受损,则会使得体内逐渐形成了痰湿因子(代谢垃圾),长期以往体内的痰湿因子不断增多,导致中焦脾胃功能衰弱,运化功能和升清降浊机能严重下滑,逐渐使四肢络脉形成瘀堵。
采取上述技术方案,具有的有益效果如下:
因此本发明结合高血压的致病原因,主要以对肝、胃、脾等脏器同调为原则,各原料药协同作用,具有祛痰、化湿、活血,利气、清热解毒、行滞化瘀等功效,不仅可化栓疏通血管,并且通过增强中焦脾胃代谢机能,加速排除血管中毒素等代谢垃圾,达到稳定降压的效果;并且通过柴胡等增强气血运行,使得人体维持阴阳平衡,调理和保护全身脏腑,维持血压正常。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:一种用于预防和治疗高血压的中药组方,其由水蛭30份、地龙25份、胡黄连20份、地骨皮40份、姜半夏25份、鱼腥草40份、甘草60份、柴胡50份、元胡35份、大青叶30份、青黛12份、四季青35份、青箱子40份、龙胆草30份、金钱草35份制成。
该实施例制成片剂型的药物,用于预防和治疗高血压。
实施例2:一种用于预防和治疗高血压的中药组方,其由水蛭45份、地龙15份、胡黄连28份、地骨皮50份、姜半夏25份、鱼腥草20份、甘草150份、柴胡20份、元胡45份、大青叶30份、青黛5份、四季青20份、青箱子25份、龙胆草20份、金钱草20份制成。
该实施例制成丸剂型的药物,用于预防和治疗高血压。
实施例3:一种用于预防和治疗高血压的中药组方,其由水蛭45份、地龙25份、胡黄连25份、地骨皮55份、姜半夏25份、鱼腥草55份、甘草150份、柴胡100份、元胡45份、大青叶45份、青黛12份、四季青45份、青箱子45份、龙胆草45份、金钱草45份制成。
该实施例制成散剂型的药物,用于预防和治疗高血压。
实施例4:一种用于预防和治疗高血压的中药组方,其由水蛭10份、地龙8份、胡黄连10份、地骨皮15份、姜半夏8份、鱼腥草15份、甘草40份、柴胡20份、元胡10份、大青叶10份、青黛5份、四季青10份、青箱子10份、龙胆草10份、金钱草15份制成。
该实施例制成口服液剂型的药物,用于预防和治疗高血压。
实施例5:临床治疗效果
选取2019年2月—2020年2月收治的48例高血压患者作为研究对象,根据治疗方法的不同分为实验组和对照组,每组24例。对照组年龄45~79岁;病程2~15年,观察组年龄55~78岁;病程2~14年。
纳入标准:
(1)符合诊断标准,要求高血压患者的舒张压≥90mmHg,收缩压≥140mmHg;
(2)患者属于原发性高血压;
(3)符合《中医病证诊断疗效标准》相关要求,患者出现头痛、眩晕、恶心、呕吐、失眠、舌苔白腻、脉弦滑等主要临床症状;
(4)患者自愿参加科学研究并且签署知情同意书。
排除标准:(1)继发性高血压患者;
(2)肝、肾等器官功能严重障碍者;
(3)不能配合医生治疗,患有精神疾病者;
(4)过敏体质或对本药过敏者。
对照组予以西药进行治疗,服用如下:给予患者服用硝苯地平控释片(拜耳医药保健有限公司;国药准字J20180025),口服使用,每次服用30mg,每日服用1次,持续用药2个月,并叮嘱患者坚持良好的生活饮食习惯,在治疗期间不可服用其他类药物。
实验组服用实施例4口服液剂型的本发明药物,每天1剂,每日服用1次,持续用药2个月。
治疗指标:
显效:患者头痛、头晕等临床症状基本消失,血压下降20mmHg以上;
有效:患者头痛、头晕等临床症状有效改善,血压下降20~10mmHg之间;
无效:患者头痛、头晕等临床症状变化不明显,血压下降10mmHg以下。
疗效对比见表1。
表1:对照组和实验组治疗疗效有效率比较
组别 | n | 显效 | 有效 | 无效 | 总有效率(%) |
对照组 | 24 | 6 | 10 | 8 | 67% |
实验组 | 24 | 8 | 14 | 2 | 91.7% |
实施例6:典型治疗案例
案例1:雷某,男,51岁,患高血压2年,最高血压在160/95mmHg,经常性烦躁、易怒,并伴有头痛、头晕等症,持续服用实施例1的药物3个月后痊愈,半年后随访,血压正常,期间无复发。
案例2:叶某,女,67岁,患高血压4年,最高血压在170/98mmHg,经常性感到头痛、眩晕,无法独自站立行走,长年服用西药无效,持续服用实施例2的药物4个月后,症状明显缓解,血压降低,继续服用至6个月后,血压恢复至正常。
案例3:刘某,男,47岁,近半年出现眩晕、耳鸣等状,精神萎靡,少寐多梦,经测量其最高血压在160/98mmHg,持续服用实施例3的药物1个半月后,眩晕、耳鸣等状明显减轻,继续服用半个月后,痊愈,血压恢复正常,眩晕、耳鸣等症状均消失。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,实施例中所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (3)
1.一种用于预防和治疗高血压的中药组方,其特征在于,其由以下原料药组成:
水蛭、地龙、胡黄连、地骨皮、姜半夏、鱼腥草、甘草、柴胡、元胡、大青叶、青黛、四季青、青箱子、龙胆草、金钱草。
2.根据权利要求1所述的一种用于预防和治疗高血压的中药组方,其特征在于,按重量计,所述原料药用量为:
水蛭5-50份、地龙3-30份、胡黄连5-30份、地骨皮10-60份、姜半夏3-30份、鱼腥草10-60份、甘草10-200份、柴胡10-100份、元胡5-50份、大青叶5-50份、青黛3-15份、四季青5-50份、青箱子5-50份、龙胆草5-50份、金钱草10-50份。
3.根据权利要求1所述的一种用于预防和治疗高血压的中药组方,其特征在于,按重量计,所述原料药用量为:
水蛭30份、地龙25份、胡黄连20份、地骨皮40份、姜半夏25份、鱼腥草40份、甘草60份、柴胡50份、元胡35份、大青叶30份、青黛12份、四季青35份、青箱子40份、龙胆草30份、金钱草35份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110845957.6A CN113413431A (zh) | 2021-07-26 | 2021-07-26 | 一种用于预防和治疗高血压的中药组方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110845957.6A CN113413431A (zh) | 2021-07-26 | 2021-07-26 | 一种用于预防和治疗高血压的中药组方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113413431A true CN113413431A (zh) | 2021-09-21 |
Family
ID=77718271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110845957.6A Pending CN113413431A (zh) | 2021-07-26 | 2021-07-26 | 一种用于预防和治疗高血压的中药组方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113413431A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114306420A (zh) * | 2022-01-19 | 2022-04-12 | 佘俊峰 | 一种降压的中药制剂及其制作方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031102A (zh) * | 2015-09-11 | 2015-11-11 | 宋克垣 | 一种治疗高血压的药物及其制备方法 |
CN108143783A (zh) * | 2018-02-26 | 2018-06-12 | 潘秀华 | 一种治疗高血压的中药含片的制备方法 |
-
2021
- 2021-07-26 CN CN202110845957.6A patent/CN113413431A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031102A (zh) * | 2015-09-11 | 2015-11-11 | 宋克垣 | 一种治疗高血压的药物及其制备方法 |
CN108143783A (zh) * | 2018-02-26 | 2018-06-12 | 潘秀华 | 一种治疗高血压的中药含片的制备方法 |
Non-Patent Citations (1)
Title |
---|
刘胜和: "龙胆泻肝汤的临床运用体会", 中国民间疗法, vol. 10, no. 12, 31 December 2002 (2002-12-31), pages 46 - 47 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114306420A (zh) * | 2022-01-19 | 2022-04-12 | 佘俊峰 | 一种降压的中药制剂及其制作方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101391077B (zh) | 一种治疗慢性盆腔炎的中药制备方法 | |
CN103690729B (zh) | 一种治疗胆道蛔虫症的中药 | |
CN104689066A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
CN103877247A (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN102188638A (zh) | 一种治疗肝癌的药物 | |
CN113413431A (zh) | 一种用于预防和治疗高血压的中药组方 | |
CN104083438A (zh) | 一种缓解高血压的苦瓜中药制剂及制备方法 | |
CN103920006A (zh) | 一种预防麻醉后寒战的药物组合物 | |
CN104524481B (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN103623280A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN105311492A (zh) | 一种用于冠状动脉粥样硬化性心脏病的药物 | |
CN110151883A (zh) | 一种调理心脑血管疾病的中药外用喷剂及其应用 | |
CN105535495A (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN102793904B (zh) | 一种治疗烦乱型闭合性骨折的中药洗剂制备方法 | |
CN102824622B (zh) | 一种治疗心悸型闭合性骨折的中药洗剂制备方法 | |
CN107998256A (zh) | 治疗胃炎的缓释片及其制备方法 | |
CN102824563B (zh) | 一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 | |
CN107260978B (zh) | 一种治疗高血压的中药组合物及其制备方法和用途 | |
CN102793868B (zh) | 一种治疗喘促型闭合性骨折的中药洗剂制备方法 | |
CN104800772A (zh) | 一种治疗气郁型冠心病的中药组合物及应用 | |
CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN104524535B (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN108079113A (zh) | 一种治疗产后血虚的药物组合物及其制备方法 | |
CN103845670A (zh) | 治疗冠状动脉粥样硬化的冲剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |